Business Context and Reporting Period
This Form 8-K reports on the results of the 2016 Annual Meeting of Stockholders held by MacroGenics, Inc. on May 18, 2016. The report was filed on May 20, 2016. As of the record date of March 29, 2016, there were 34,536,521 shares of common stock outstanding. A total of 30,502,648 shares were present or represented by proxy, representing approximately 88.32% of the outstanding shares.
Key Financial Metrics
This filing is a Current Report regarding corporate governance and shareholder voting results. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Voting Results
The filing details the outcomes of four proposals submitted to stockholders:
- Proposal 1 (Election of Directors): Both Class III nominees, Paulo Costa and Edward Hurwitz, were elected for three-year terms.
- Paulo Costa: 25,921,264 votes For; 1,058,377 votes Withheld.
- Edward Hurwitz: 25,865,896 votes For; 1,113,745 votes Withheld.
- Proposal 2 (Ratification of Auditors): The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2016 was approved.
- For: 30,169,021
- Against: 230,487
- Abstain: 103,140
- Proposal 3 (Executive Compensation Advisory Vote): The compensation of named executive officers was approved on an advisory basis.
- For: 26,558,778
- Against: 300,449
- Abstain: 120,414
- Broker Non-Votes: 3,523,007
- Proposal 4 (Frequency of Compensation Votes): Stockholders voted on the frequency of future advisory votes on executive compensation. The majority voted for an annual (1-year) frequency.
- 1 Year: 21,017,005
- 2 Years: 176,490
- 3 Years: 3,458,946
- Abstain: 2,327,200
- Broker Non-Votes: 3,523,007
Guidance, Outlook, and Management Commentary
Following the annual meeting, the Board of Directors determined that the Company would conduct an annual non-binding, advisory vote on named executive officer compensation, aligning with the outcome of the shareholder vote on Proposal 4. The filing contains no financial guidance, outlook, risk factors, or discussion of unusual items.
Important Facts for Investors to Verify
- Confirmation that Ernst & Young LLP has been ratified as the independent auditor for fiscal year 2016.
- Verification of the new Class III directors (Paulo Costa and Edward Hurwitz) joining the Board.
- Confirmation that future executive compensation advisory votes will occur annually.
- Review of the definitive proxy statement filed on April 7, 2016, for detailed background on the proposals.